Rockwell Medical (RMTI) EBITDA Margin (2010 - 2026)
Rockwell Medical (RMTI) posted EBITDA Margin of 8.54% for Q1 2026, down 293.52% on a QoQ basis from 2.17% in Q4 2025, and down 135.0% year-over-year from 24.39% in Q1 2025.
Rockwell Medical (RMTI) EBITDA Margin (2010 - 2026) Analysis & Trends
Rockwell Medical's EBITDA Margin history runs 17 years deep, the most recent figure standing at 8.54% for Q1 2026.
- Quarterly EBITDA Margin fell 135.0% year-over-year to 8.54% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.11% (down 769.0% YoY) and the FY2025 annual result came in at 6.77%, down 737.0% from the prior year.
- EBITDA Margin was 8.54% for Q1 2026 at Rockwell Medical, down from 2.17% in the prior quarter.
- Across five years, EBITDA Margin topped out at 6.84% in Q3 2024 and bottomed at 41.09% in Q1 2022.
- A 5-year average of 9.64% and a median of 7.31% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin jumped 4434 bps — and 2025, when it plunged 1678 bps.
- Rockwell Medical's EBITDA Margin stood at 10.18% in 2022, then jumped by 76 bps to 2.48% in 2023, then climbed by 15 bps to 2.1% in 2024, then dropped by 3 bps to 2.17% in 2025, then slumped by 294 bps to 8.54% in 2026.
- Business Quant data shows RMTI's EBITDA Margin at 8.54% in Q1 2026, 2.17% in Q4 2025, and 9.95% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -8.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.54% |
| Dec 31, 2025 | -2.17% |
| Sep 30, 2025 | -9.95% |
| Jun 30, 2025 | -8.39% |
| Mar 31, 2025 | -7.19% |
| Dec 31, 2024 | -2.10% |
| Sep 30, 2024 | 6.84% |
| Jun 30, 2024 | 1.99% |
| Mar 31, 2024 | -5.84% |
| Dec 31, 2023 | -2.48% |
| Sep 30, 2023 | -7.31% |
| Jun 30, 2023 | -16.37% |
| Mar 31, 2023 | -7.26% |
| Dec 31, 2022 | -10.18% |
| Sep 30, 2022 | -19.84% |
| Jun 30, 2022 | -23.99% |
| Mar 31, 2022 | -41.09% |
| Dec 31, 2021 | -54.52% |
| Sep 30, 2021 | -43.61% |
| Jun 30, 2021 | -51.68% |